Allstate Corporation’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.93M | Buy |
10,978
+4,478
| +69% | +$1.21M | 0.03% | 374 |
|
|
2025
Q4 | $1.63M | Buy |
6,500
+2,863
| +79% | +$760K | 0.02% | 415 |
|
|
2025
Q3 | $1.04M | Buy |
+3,637
| New | +$974K | 0.02% | 351 |
|
|
2025
Q2 | – | Sell |
-4,324
| Closed | -$1.01M | – | 393 |
|
|
2025
Q1 | $1.01M | Buy |
4,324
+1,746
| +68% | +$424K | 0.03% | 343 |
|
|
2024
Q4 | $591K | Buy |
+2,578
| New | +$591K | 0.02% | 436 |
|
|
2023
Q1 | – | Sell |
-4,563
| Closed | -$923K | – | 410 |
|
|
2022
Q4 | $923K | Buy |
4,563
+49
| +1% | +$9.58K | 0.03% | 368 |
|
|
2022
Q3 | $794K | Buy |
4,514
+864
| +24% | +$177K | 0.02% | 398 |
|
|
2022
Q2 | $735K | Sell |
3,650
-10
| -0.3% | -$2.13K | 0.02% | 414 |
|
|
2022
Q1 | $829K | Sell |
3,660
-7,436
| -67% | -$1.75M | 0.02% | 430 |
|
|
2021
Q4 | $3M | Buy |
11,096
+7,443
| +204% | +$1.84M | 0.06% | 298 |
|
|
2021
Q3 | $883K | Sell |
3,653
-308
| -8% | -$77.6K | 0.04% | 319 |
|
|
2021
Q2 | $939K | Sell |
3,961
-274
| -6% | -$62.4K | 0.03% | 323 |
|
|
2021
Q1 | $928K | Buy |
4,235
+263
| +7% | +$52.8K | 0.03% | 335 |
|
|
2020
Q4 | $695K | Buy |
3,972
+194
| +5% | +$33.5K | 0.02% | 373 |
|
|
2020
Q3 | $611K | Buy |
3,778
+1,509
| +67% | +$239K | 0.02% | 353 |
|
|
2020
Q2 | $324K | Sell |
2,269
-305
| -12% | -$42.2K | 0.01% | 558 |
|
|
2020
Q1 | $279K | Buy |
+2,574
| New | +$371K | 0.01% | 510 |
|
|
2019
Q4 | – | Sell |
-3,066
| Closed | -$443K | – | 628 |
|
|
2019
Q3 | $443K | Sell |
3,066
-9,726
| -76% | -$1.42M | 0.01% | 442 |
|
|
2019
Q2 | $1.9M | Buy |
12,792
+9,726
| +317% | +$1.36M | 0.03% | 285 |
|
|
2019
Q1 | $403K | Buy |
+3,066
| New | +$378K | 0.01% | 355 |
|
|
2017
Q3 | – | Sell |
-7,473
| Closed | -$990K | – | 157 |
|
|
2017
Q2 | $990K | Buy |
+7,473
| New | +$915K | 0.05% | 190 |
|
|
2015
Q4 | – | Sell |
-29,255
| Closed | -$2.73M | – | 192 |
|
|
2015
Q3 | $2.73M | Buy |
29,255
+4,229
| +17% | +$437K | 0.28% | 103 |
|
|
2015
Q2 | $2.61M | Buy |
+25,026
| New | +$2.6M | 0.23% | 92 |
|
|
2014
Q2 | – | Sell |
-156,365
| Closed | -$13.2M | – | 227 |
|
|
2014
Q1 | $13.2M | Hold |
156,365
| – | – | 0.43% | 60 |
|
|
2013
Q4 | $12.3M | Sell |
156,365
-93,332
| -37% | -$7.96M | 0.46% | 53 |
|
|
2013
Q3 | $21.3M | Buy |
249,697
+81,651
| +49% | +$6.88M | 0.83% | 34 |
|
|
2013
Q2 | $14.5M | Buy |
+168,046
| New | +$14M | 0.66% | 31 |
|
Other funds holding LH
VCM
VPM
Allstate Corporation's LH Position: Q1 2026 in Review
Allstate Corporation increased its Labcorp (LH) stake by 69% in Q1 2026, buying an estimated $1.21M and bringing the position to 10,978 shares worth $2.93M. The position accounts for 0.03% of the portfolio, ranked #374.
Allstate Corporation first reported a position in LH in Q2 2013 and has held it in 27 quarters since. The position peaked at $21.3M in Q3 2013. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Allstate Corporation held 10,978 shares of Labcorp worth $2.93M as of Q1 2026.
- Allstate Corporation bought 4,478 Labcorp shares in Q1 2026, an estimated $1.21M.
- Labcorp made up 0.03% of Allstate Corporation's portfolio in Q1 2026, its #374 holding.
- Allstate Corporation first reported a position in Labcorp in Q2 2013 and has held it in 27 quarters since.
- Allstate Corporation's Labcorp position peaked at $21.3M in Q3 2013.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.